• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Naphthoylindoles

Professional Introduction to Compound with CAS No. 1427325-32-3 and Product Name: (2-hydroxy-1-pentyl-1H-indol-3-yl)(1-naphthyl)methanone

The compound with the CAS number 1427325-32-3 and the product name (2-hydroxy-1-pentyl-1H-indol-3-yl)(1-naphthyl)methanone represents a significant advancement in the field of pharmaceutical chemistry. This molecule, characterized by its intricate structural framework, has garnered considerable attention due to its potential applications in medicinal chemistry and drug development. The presence of both indole and naphthyl moieties in its structure suggests a unique set of pharmacological properties that make it a promising candidate for further investigation.

Structurally, the compound consists of a (2-hydroxy-1-pentyl-1H-indol-3-yl) moiety linked to a (1-naphthyl)methanone group. The indole ring system is well-known for its biological activity and is a common structural motif in many bioactive natural products and pharmaceuticals. The hydroxyl group at the 2-position of the indole ring introduces a polar functional group that can enhance solubility and interact with biological targets. Additionally, the pentyl side chain at the 1-position adds bulk to the molecule, potentially influencing its binding affinity and metabolic stability.

The naphthyl group in the (1-naphthyl)methanone moiety contributes to the compound's hydrophobicity and may play a crucial role in its interaction with biological receptors. Naphthalene derivatives are known for their diverse pharmacological activities, including anti-inflammatory, antimicrobial, and anticancer properties. The methanone bridge connecting the indole and naphthyl groups provides structural stability while allowing for conformational flexibility, which is essential for effective binding to biological targets.

Recent research in medicinal chemistry has highlighted the importance of hybrid molecules that combine different pharmacophoric units. The compound (2-hydroxy-1-pentyl-1H-indol-3-yl)(1-naphthyl)methanone exemplifies this approach by integrating two distinct scaffold structures. Such hybrid molecules often exhibit enhanced biological activity compared to their individual components due to synergistic interactions between the different pharmacophores.

In vitro studies have begun to explore the potential of this compound as a lead molecule for drug development. Initial experiments have shown promising results in terms of binding affinity to various biological targets, including enzymes and receptors involved in critical cellular pathways. The (2-hydroxy-1-pentyl-1H-indol-3-yl) moiety has been found to interact effectively with proteins rich in aromatic residues, while the (1-naphthyl)methanone group contributes to binding interactions through hydrophobic and π-stacking interactions.

One of the most exciting aspects of this compound is its potential application in treating neurological disorders. Indole derivatives are known for their role in modulating neurotransmitter systems, and naphthalene-based compounds have shown promise in treating conditions such as Alzheimer's disease and Parkinson's disease. The unique combination of these structural elements in (2-hydroxy-1-pentyl-1H-indol-3-yl)(1-naphthyl)methanone may offer a novel therapeutic approach for these debilitating conditions.

Furthermore, the compound's metabolic stability has been evaluated through computational modeling and experimental assays. The presence of the pentyl side chain appears to enhance metabolic resistance, making it a more suitable candidate for longer-term therapeutic use. Additionally, the hydroxyl group at the 2-position of the indole ring may serve as a site for further chemical modification, allowing for the development of analogs with improved pharmacokinetic properties.

Future research will focus on synthesizing derivatives of this compound to optimize its pharmacological profile. By modifying various functional groups within the molecule, researchers aim to enhance its binding affinity, selectivity, and bioavailability. Techniques such as structure-activity relationship (SAR) studies will be employed to identify key structural features responsible for biological activity.

The development of new pharmaceuticals is a complex process that requires careful consideration of multiple factors, including efficacy, safety, and manufacturability. However, compounds like (2-hydroxy-1-pentyl-1H-indol-3-yl)(1-naphthyl)methanone offer hope by providing innovative starting points for drug discovery efforts. As our understanding of molecular interactions continues to evolve, such hybrid molecules will play an increasingly important role in addressing unmet medical needs.

In conclusion, the compound with CAS number 1427325-32-3 and product name (2-hydroxy-1-pentyl-1H-indol-3-yl)(1-naphthyl)methanone represents a significant advancement in pharmaceutical chemistry. Its unique structural features and promising biological activities make it a valuable candidate for further research and development. As scientists continue to explore new frontiers in drug discovery, compounds like this one highlight the potential of innovative molecular design to address complex diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)